Dr. Hillary Lin, Stanford-trained internist and co-founder and CEO of CareCore, joined Sunita Mohanty, co-founder and CEO of Ultralight. This week's editorial came out of the session; the full conversation goes deeper on tactics.
This week I sat down with Dr. Hillary Lin, a Stanford-trained physician and one of the best long-form health educators on YouTube, to talk about the thing most of us were trained not to do: build a public voice.
Why now? A few weeks ago, The New York Times found hundreds of fully synthetic doctors selling supplements on American feeds. And the audience is real: KFF's latest tracking poll finds 31% of adults now turn to social media for health information at least monthly — with another 29% asking AI chatbots, a share that has nearly doubled in two years.
Hillary's take on why the fakes work: "People want to be able to rely on a real human being, a trusted clinical human being." What they get instead is "a quick fix for a much deeper craving." The craving is a relationship with a clinician they trust.
The fakes are selling an imitation of you.
Why you were trained to stay quiet
If posting makes you uneasy, that's your training working as designed. The AMA's ethics opinion on social media warns that online activity can undermine public trust and carry career consequences, and state boards enforce it. Hillary got the standard talk at Stanford: be extremely careful online, don't even post what you'd normally post. When one privacy mistake can reach your board, silence was the rational default.
That math has flipped. A decade ago, staying quiet cost nothing. Now your empty slot in the feed gets filled and increasingly by something synthetic. And as AI content floods every platform, the scarce asset in health media is a real, verifiable, independent clinician.
You already are one. The question is whether patients can find you.
Start with why, not the camera
Hillary's framework has three layers:
Your why: the foundation
Presentation: how clearly you communicate
Production: filming, editing, posting
Agencies sell layer three first (she's seen $30,000/month retainers). It matters least. Get your why straight and the rest gets easy.
Your why doesn't have to be noble, just honest. Grow the practice. Teach at scale. Open doors to speaking and media. Advocate for something you've lived. Each points to a different platform and a different number to track: booked consults, sign-ups, invitations. Follower count tells you the least.
Pick depth over reach
Her platform logic: longer formats hold deeper attention, and deeper attention means higher intent. Short clips catch people scrolling. Long form holds people making decisions — and health decisions get weighed for years. Depth is your advantage, not your handicap.
Whatever you build, start an email list. Every platform audience belongs to the platform. The list is the only audience you own.
The rules that aren't optional
Real patient stories, fine. Recognizable patients, never. Change every detail that doesn't carry the lesson.
Educate, don't treat.
Stay inside the evidence. The public can't filter an overgeneralized pilot study.
Disclose every financial relationship. Skip pitches for anything you don't use.
What to try this week
Write your why in one paragraph. Before you touch a camera or a contract.
Pick one channel that fits your temperament. Unsure? LinkedIn has the lowest friction.
Answer the question your patients ask most. Plain language, imperfectly produced, identifying details stripped.
Hillary's full playbook covers hiring costs at every tier and a realistic two-year timeline.
Her parting advice covers all of it: "Don't outsource your own learning."
Be a modern clinician with the help of Ultralight, the AI-native EHR built specifically for functional, integrative, and longevity medicine. We’ve recently launched wearables integrations and improved AI-native clinical workflows - get in touch to see the latest updates.
In the news
Tirzepatide tracked with a third fewer heart attacks in older adults with type 2 diabetes. In a claims analysis of 52,971 patients with a mean age of 70, tirzepatide was associated with 32% lower one-year risk of major cardiovascular events than sitagliptin (2.9% vs 4.4%), with lower mortality and no difference in ischemic stroke. Observational rather than randomized, but it is the real-world cardiovascular datapoint your GLP-1 patients will bring to their next visit.
Clean vascular health at midlife tracked with nearly 13 more dementia-free years. Among 12,409 adults followed for about 26 years, those free of diabetes, hypertension, and smoking at 55 averaged 30 dementia-free years against 17.5 for those with all three risk factors. One quotable number for treating blood pressure, glucose, and smoking as brain-longevity work in the 45-to-60 consult.
A new analysis puts numbers on the 2025 blood pressure guideline: about 23 million more Americans qualify for medication. The NHANES study found 28% of US adults with hypertension and no cardiovascular disease are newly treatment-eligible, 9.7 million of them currently untreated. Millions of patients just moved from lifestyle-only to a medication conversation, and lifestyle-first practices are set up to lead it inside the new thresholds.
Upcoming Conferences & Events
Sept 18-19, Dr. Kara Fitzgerald Masterclass “Functional Medicine Is Longevity Medicine”· Online · Led by Kara Fitzgerald, this year’s Masterclass will continue under the theme that functional medicine is longevity medicine. Not as a trend, but as the most science-backed, clinically effective path to extending healthspan. Ultralight will be there!
Sept 22–23, MVMNT Longevity Medicine Summit · Coronado, CA · Evidence-graded longevity science, hands-on labs, and clinical frameworks you can implement the week after. Capped at 300 clinicians. Ultralight will be there!
Oct 8–10, A4M Women's Health Summit · San Antonio, TX · The best clinical education on hormone, metabolic, and midlife women's health you will see this year. The room to be in if you are growing the perimenopause and menopause side of your practice.
Oct 21–24, NAMS Annual Meeting · San Diego, CA · The single most practice-changing meeting of the year for midlife women's health. Your protocols will look different after this one.
Nov 5–8, Eudēmonia Summit · West Palm Beach, FL · One of the most talked-about longevity gatherings in the U.S. Experientials, hands-on demos, and the best place to try the emerging frameworks your patients will ask you about next year. OvationLab and Ultralight will be there!
Nov 5-7, Private Physicians Alliance Annual Meeting · St. Petersburg, FL · The gathering for independent, cash-pay, and concierge physicians navigating practice independence. Practical and peer-driven. Ultralight will be there!
Nov 8-11, American College of Lifestyle Medicine Conference · Orlando, FL · Lifestyle medicine's main annual event — evidence-based approaches to behavior change, chronic disease, and healthspan. Growing overlap with the longevity medicine community.
Dec 11–13, A4M Longevity Fest · Las Vegas, NV · The biggest longevity event in the U.S. The room spans clinicians, industry, founders, and the people building next year's platforms, and the connections from this one tend to compound through the rest of your year. OvationLab and Ultralight will be there!
Know of an event we should add? Reply and tell us.
Until next week
For over a decade the safe read on social media was silence, and the institutions that trained doctors said so in writing. The feeds filled with synthetic doctors anyway. The clinicians best placed to answer them are independent ones like you, and the advantage is sitting there unspent.
Reply and tell us whether you post, and if you do not, what has held you back. The best ideas in this newsletter come from clinicians doing the work.
Until next week, keep building the practice you imagined when you started.
— Dr. G and Sunita